Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials – an example in hemato-oncology
Crossref DOI link: https://doi.org/10.1186/s12874-016-0166-7
Published Online: 2016-06-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jacob, Louis
Uvarova, Maria
Boulet, Sandrine
Begaj, Inva
Chevret, Sylvie
Funding for this research was provided by:
INCA (2014-132, R14208KK)